Remove 2030 Remove Biopharma Remove Collaboration
article thumbnail

The Future of Proteomics: Innovations, Challenges, and Industry Growth (2024-2030)

Frost & Sullivan

The global proteomics industry is poised for significant expansion between 2024 and 2030, driven by advances in research and pharmaceutical applications. Collaborations with academic institutions and clinical research centers will further drive innovation and expand market opportunities. of Competitors 80, with revenue greater than $1.0

article thumbnail

DCAT Week 2025: Key Takeaways & Industry Advancements

Frost & Sullivan

As pharmaceutical innovation continues to reshape the industry, key focuses at DCAT Week 2025 included manufacturing capacity expansion, supply chain resilience, digital transformation, and strategic collaborations. trillion in 2024, is expected to grow at a 7% CAGR through 2030.